Evidence map›Paper›PMID 21123458›Full record

Trial reportThe American journal of clinical nutrition2011

MTHFR C677T genotype influences the isotopic enrichment of one-carbon metabolites in folate-compromised men consuming d9-choline.

Jian Yan, Wei Wang, Jesse F Gregory, Olga Malysheva, J Thomas Brenna, Sally P Stabler, Robert H Allen, Marie A Caudill

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Genetic impairments in folate enzymes increase dependence on dietary choline for phosphatidylcholine production at the expense of betaine synthesis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Jian YanDivision of Nutritional Sciences and Genomics, Cornell University, Ithaca, NY 14853, USA.
Wei Wang
Jesse F Gregory
Olga Malysheva
J Thomas Brenna
Sally P Stabler
Robert H Allen
Marie A Caudill
Cornell University · USUniversity of Colorado Denver · USCalifornia State Polytechnic University · USPediatrics and Genetics · USUniversity of Florida · US

Funding

The Response of Choline and Folate Status to Controlled Levels of Choline IntakeS06GM053933 · NIGMS · CALIFORNIA STATE POLY U POMONA · PI BUCKLEY-NIEVES, NANCY E · 1997 to 2007
$15.1M
Vitamin B6 Effects on One-Carbon MetabolismR01DK072398 · NIDDK · UNIVERSITY OF FLORIDA · PI GREGORY, JESSE F. · 2005 to 2013
$3.3M
NIDDK NIH HHS R01 DK072398NIGMS NIH HHS S06GM053933
6 · The paper itself

Abstract

backgroundHomozygosity for the variant 677T allele in the methylenetetrahydrofolate reductase (MTHFR) gene increases the requirement for folate and may alter the metabolic use of choline. The choline adequate intake is 550 mg/d for men, although the metabolic consequences of consuming extra choline are unclear.

objectiveDeuterium-labeled choline (d9-choline) as tracer was used to determine the differential effects of the MTHFR C677T genotype and the effect of various choline intakes on the isotopic enrichment of choline derivatives in folate-compromised men.

designMexican American men with the MTHFR 677CC or 677TT genotype consumed a diet providing 300 mg choline/d plus supplemental choline chloride for total choline intakes of 550 (n = 11; 4 with 677CC and 7 with 677TT) or 1100 (n = 12; 4 with 677CC and 8 with 677TT) mg/d for 12 wk. During the last 3 wk, 15% of the total choline intake was provided as d9-choline.

resultsLow but measurable enrichments of the choline metabolites were achieved, including that of d3-phosphatidylcholine (d3-PtdCho)--a metabolite produced in the de novo pathway via choline-derived methyl groups. Men with the MTHFR 677TT genotype had a higher urinary enrichment ratio of betaine to choline (P = 0.041), a higher urinary enrichment of sarcosine (P = 0.041), and a greater plasma enrichment ratio of d9-betaine to d9-PtdCho with the 1100 mg choline/d intake (P = 0.033).

conclusionThese data show for the first time in humans that choline itself is a source of methyl groups for de novo PtdCho biosynthesis and indicate that the MTHFR 677TT genotype favors the use of choline as a methyl donor.

Indexed as

AdolescentAdultBetaineCholineDeuteriumDietary SupplementsFolic Acid DeficiencyGenotypeHumansMaleMethylationMethylenetetrahydrofolate Reductase (NADPH2)Mexican AmericansMiddle AgedPhosphatidylcholinesSarcosineBetaineCholineDeuteriumMethylenetetrahydrofolate Reductase (NADPH2)PhosphatidylcholinesSarcosine

Identifiers

PMID21123458
PMCPMC3021427
OpenAlexW2128348689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.